These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 22873529

  • 1. Use patents, carve-outs, and incentives--a new battle in the drug-patent wars.
    Rai A.
    N Engl J Med; 2012 Aug 09; 367(6):491-3. PubMed ID: 22873529
    [No Abstract] [Full Text] [Related]

  • 2. On access and accountability--two Supreme Court rulings on generic drugs.
    Boumil MM, Curfman GD.
    N Engl J Med; 2013 Aug 22; 369(8):696-7. PubMed ID: 23923990
    [No Abstract] [Full Text] [Related]

  • 3. Generics still unable to resolve ANDA patent issues by declaratory judgment, but is a supreme court resolution on the way?
    Eccleston LE.
    Health Care Law Mon; 2006 Dec 22; ():3-5. PubMed ID: 17236678
    [No Abstract] [Full Text] [Related]

  • 4. Patent watch: US Supreme Court revises patent claim construction standards.
    Noonan K.
    Nat Rev Drug Discov; 2015 Mar 22; 14(3):157. PubMed ID: 25722233
    [No Abstract] [Full Text] [Related]

  • 5. The Food and Drug Administration and patent law at a crossroads: the listing of polymorph patents as a barrier to generic drug entry.
    Srivastava D.
    Food Drug Law J; 2004 Mar 22; 59(2):339-54. PubMed ID: 15298015
    [No Abstract] [Full Text] [Related]

  • 6. A precarious balancing act--the role of the FDA as protector of public health and industry wealth.
    McCabe AR.
    Suffolk Univ Law Rev; 2003 Mar 22; 36(3):787-819. PubMed ID: 16493844
    [No Abstract] [Full Text] [Related]

  • 7. Old drugs, new uses: solving a Hatch-Waxman patent predicament.
    McPhie DC.
    Food Drug Law J; 2004 Mar 22; 59(1):155-68. PubMed ID: 15190929
    [No Abstract] [Full Text] [Related]

  • 8. Intellectual property. Drug patents at the Supreme Court.
    Hemphill CS, Sampat B.
    Science; 2013 Mar 22; 339(6126):1386-7. PubMed ID: 23520096
    [No Abstract] [Full Text] [Related]

  • 9. The Drug Price Competition and Patent Term Restoration Act of 1984: fine-tuning the balance between the interests of pioneer and generic drug manufacturers.
    Soehnge H.
    Food Drug Law J; 2003 Mar 22; 58(1):51-80. PubMed ID: 12739584
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Judicial developments in the US Hatch-Waxman infringement safe harbor.
    Swirnoff AH, Becker DM.
    Expert Opin Ther Pat; 2010 Apr 22; 20(4):451-8. PubMed ID: 20302449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.